| scholarly article | Q13442814 |
| P2093 | author name string | Li Liu | |
| Dawei Xu | |||
| Magnus Björkholm | |||
| Kun Wang | |||
| Nan Ge | |||
| Chang Wang | |||
| Tiantian Liu | |||
| Cheng Liu | |||
| Hongbo Ren | |||
| Keqiang Yan | |||
| Jikai Liu | |||
| Sanyuan Hu | |||
| Yidong Fan | |||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| Molecular regulation of telomerase activity in aging | Q26861714 | ||
| Highly prevalent TERT promoter mutations in aggressive thyroid cancers | Q27852353 | ||
| Highly recurrent TERT promoter mutations in human melanoma | Q29614798 | ||
| TERT promoter mutations in familial and sporadic melanoma | Q29614920 | ||
| Regulation of the human catalytic subunit of telomerase (hTERT). | Q34180715 | ||
| 2004 WHO classification of the renal tumors of the adults | Q34488979 | ||
| Hallmarks of telomeres in ageing research | Q36698271 | ||
| TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal | Q36762656 | ||
| TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours. | Q37040678 | ||
| High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions | Q37064910 | ||
| TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism | Q37256055 | ||
| TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine | Q37663771 | ||
| Alterations in VHL as potential biomarkers in renal-cell carcinoma | Q37724576 | ||
| An overview of renal cell cancer: pathology and genetics | Q38020665 | ||
| The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas | Q39076273 | ||
| Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome | Q39098321 | ||
| Frequency of TERT promoter mutations in human cancers | Q39120274 | ||
| Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss | Q39139952 | ||
| Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells | Q39263985 | ||
| Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues | Q40408840 | ||
| Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity | Q41960593 | ||
| Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma | Q42444688 | ||
| Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma | Q43128951 | ||
| Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine | Q44413803 | ||
| von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma | Q46478024 | ||
| Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma | Q47605502 | ||
| Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma. | Q47704838 | ||
| EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma | Q49136169 | ||
| Renal-Cell Carcinoma | Q56019528 | ||
| Catalytic Subunit of Human Telomerase Reverse Transcriptase Is an Independent Predictor of Survival in Patients Undergoing Curative Resection of Hepatic Colorectal Metastases: A Multicenter Analysis | Q60629744 | ||
| Expression of telomerase catalytic subunit (hTERT) mRNA does not predict survival in patients with transitional cell carcinoma of the upper urinary tract | Q77162259 | ||
| Telomerase expression predicts unfavorable outcome in osteosarcoma | Q80558291 | ||
| Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view | Q82016162 | ||
| Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma | Q82981464 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1829-1836 | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas | |
| P478 | volume | 5 |
| Q26738705 | Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications |
| Q47916891 | Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma. |
| Q35901458 | Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis |
| Q89945283 | Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors |
| Q92664567 | Diverse regulatory manners of human telomerase reverse transcriptase |
| Q49721662 | Evolving Treatment Paradigms in Non-clear Cell Kidney Cancer. |
| Q92372118 | Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma |
| Q36103321 | High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma |
| Q92783759 | Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers |
| Q42253044 | Non-blood circulating tumor DNA detection in cancer |
| Q26744271 | Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies |
| Q43274590 | Sensitive droplet digital PCR method for detection of TERT promoter mutations in cell free DNA from patients with metastatic melanoma |
| Q54310538 | Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types. |
| Q54522397 | TERT Promoter Hypermethylation in Gastrointestinal Cancer: A Potential Stool Biomarker. |
| Q54347306 | TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA. |
| Q38774845 | TERT promoter mutation status in sarcomatoid urothelial carcinomas of the upper urinary tract |
| Q35151119 | TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer |
| Q34654382 | TERT promoter mutations and gene amplification: promoting TERT expression in Merkel cell carcinoma |
| Q35833084 | TERT promoter mutations and telomere length in adult malignant gliomas and recurrences. |
| Q35068013 | TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR |
| Q54314475 | TERT promoter mutations in clear cell renal cell carcinoma. |
| Q93187690 | Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations |
| Q38232447 | Telomerase promoter mutations in cancer: an emerging molecular biomarker? |
| Q40199208 | Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change |
| Q47764734 | Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer |
| Q37317414 | Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma. |
| Q55443450 | Telomere Maintenance Mechanisms in Cancer. |
| Q98158989 | Telomeres and telomerase in oncogenesis |
| Q91436228 | The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma |
| Q33618591 | The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma |
| Q28392404 | The association between the TERT rs2736100 AC genotype and reduced risk of upper tract urothelial carcinomas in a Han Chinese population |
| Q37295512 | The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent FGFR3 mutation in Han Chinese patients |
| Q26739925 | Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene |
| Q33276030 | Upregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis |
Search more.